386:HKEXChina Petroleum & Chemical Corporation Class H Analysis

EPS Creative Health Technology Group is trading at HK$0.66, which sits below its 20‑day (HK$0.6745) and 50‑day (HK$0.6726) simple moving averages and just above the identified support level of HK$0.61, suggesting limited upside in the near term. Technical signals are mixed: the 14‑day RSI at 48 is neutral, the MACD histogram is negative and the MACD line is below its signal line, indicating bearish momentum, while the overall trend is still classified as bullish. Volume is decreasing and 30‑day volatility is high at roughly 50%, underscoring a choppy price environment. On the fundamentals side, revenue has contracted by 35% year‑over‑year and operating margins are marginally negative, yet the company holds a solid cash buffer of HK$138 million against HK$58 million of debt, yielding a comfortable net‑cash position. The dividend yield of 1.54% is backed by a payout ratio of about 26%, which appears sustainable given the cash strength. A discounted cash flow model places fair value near HK$1.30, more than double the current price, pointing to a potential undervaluation despite the weak earnings momentum.